GlassScriptPhysician profile
Joseph H Guettler
NPI 1629069869
$22,850.12
in general payments reported to CMS, 2019-2025
19 companies · $1,066 in 2025
The $1,066 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $1,100 · 2021: $1,499 · 2022: $4,573 · 2023: $2,261 · 2024: $1,193 · 2025: $1,066.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,396 · Travel and Lodging: $1,124.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,396.25 |
| Travel and Lodging | $1,124.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $8,664.98 | 2019-2025 | Healicoil, Bioinductive Implant With Arthroscopic Delivery System - Medium, Bone Anchors With Arthroscopic Delivery System |
| Pinnacle, INC | $3,470.71 | 2019-2025 | |
| Vericel Corporation | $3,137.31 | 2019-2025 | Maci |
| Arthrex, INC. | $2,345.98 | 2019-2023 | |
| Stryker Corporation | $1,666.97 | 2019-2024 | Aequalis Perform, Inspace, Mako |
| Horizon Therapeutics Plc | $883.91 | 2019-2022 | |
| Zimmer Biomet Holdings, INC. | $759.69 | 2019-2024 | Juggerknotless Soft Anchor |
| Depuy Synthes Sales INC. | $520.58 | 2021-2025 | Gryphon Orthocord, Va-Lcp, Truespan Orthocord |
| Djo, LLC | $364.38 | 2023-2025 | Aircast, Donjoy, Procare |
| Miach Orthopaedics, INC. | $346.95 | 2024 | |
| Wright Medical Technology, INC. | $205.96 | 2019 | |
| Bioventus LLC | $177.67 | 2024-2025 | Xcell, Durolane |
| Catalyst Orthoscience | $105.75 | 2022 | |
| Pacira Therapeutics, INC. | $104.98 | 2019 | |
| Davol INC. | $22.92 | 2025 | Arista |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fidia Pharma USA INC. | $19.71 | 2024 | Hymovis |
| Averitas Pharma INC. | $19.59 | 2023 | Qutenza |
| Pacira Pharmaceuticals Incorporated | $18.12 | 2022 | |
| Stimwave Technologies Incorporated | $13.96 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Guettler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.